Skip to content

Effectiveness of concentrated growth factor and platelet rich fibrin for Treatment of human periodontal defects

A Comparative Evaluation of Effectiveness of Concentrated Growth Factor (CGF) and Platelet rich fibrin (PRF) alone in the Treatment of Human Infrabony Defectsâ?? A Clinical and Radiographic Study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019461
Enrollment
10
Registered
2019-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Concentrated Growth Factor: CGF is an advanced second generation platelet concentrate, obtained with differential continuous centrifugal technology, containing many kinds of growth fact

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of at least 1 or 2 radiographically detectable interproximal intrabony osseous defect with probing pocket depth >= 5 mm and clinical attachment loss >= 5 mm following initial therapy. 2. Depth of intraosseous component of the defect >= 3 mm by clinical and radiographic means, which will be confirmed on intrasurgical measurment 3. A radiographic base of the defect at least 3 mm coronal to the apex of the tooth. 4. Presence of at least 3 mm width of keratinized gingiva around test teeth to allow complete soft tissue coverage of the defect.

Exclusion criteria

Exclusion criteria: 1. Evidence of localized aggressive periodontitis. 2. Patients with unacceptable oral hygiene (Plaque Index >1) 3. Smokers (recent history of smoking more than 10 cigarettes /day) or who used any of tobacco products. 4. Study tooth with inadequate endodontic / restorative treatments. 5. Study tooth with mobility exceeding grade II and exhibiting a class III or class IV furcation defect. 6. History of periodontal surgical therapy of the selected quadrant. 7. Pregnant females or lactating mothers. 8. Clinical or radiographic signs of untreated acute infection at the selected site, apical pathology, root fracture, severe root irregularities, cemental pearls, cementoenamel projections not easily removed by odontoplasty, untreated carious lesions at cementoenamel junction (CEJ) or on the root surface.

Design outcomes

Primary

MeasureTime frame
Probing Pocket Depth Clinical Attachment LevelTimepoint: baseline, 3 months, 6 months, 9 months

Secondary

MeasureTime frame
Periodontal healthTimepoint: baseline, 3 months, 6 months, 9 months

Countries

India

Contacts

Public ContactDr Priyanka Jaiswal

Datta Meghe Institute of Medical Sciences

priyanka.banode@gmail.com9960713010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026